Impact of guideline-recommended medical therapy at discharge on long-term mortality in patients with or without left ventricular dysfunction after primary PCI for STEMI

3 September 2019 (10:05 - 10:55)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Dejan Milasinovic

University Clinical Center of Serbia, Belgrade (Serbia)

6 More presentations in this session

Presentation thumbnail

Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry

Professor G. Ducrocq (Paris, FR)

Abstract Slides

Presentation thumbnail

The major bleeding event is the stronger predictor of long term mortality rather than the coronary event in the secondary prevention of ischemic heart disease in Japan

Doctor S. KAGEYAMA (Shizuoka, JP)

Abstract Slides

Presentation thumbnail

Ten-year trends and outcomes in cardiogenic shock related to first-time acute myocardial infarction: a nationwide population-based cohort study.

Miss M. Dam Lauridsen (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

Trends in hospitalised cardiac arrest outcomes over 25 years in Scotland

Doctor R. Bing (Edinburgh, GB)

Abstract Slides

Presentation thumbnail

The NPAC score for predicting survival after incident acute myocardial infarction

Mr K. Li (Newcastle-Upon-Tyne, GB)

Abstract Slides

Access the full session

Session thumbnail

Challenges in contemporary management of coronary artery disease

The Event

ESC Congress 2019

3 September 2019 10:05 CET

You may be interested in

Congress Session

Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

Congress Presentation

From hypertension to heart failure: pathophysiology

Congress Session

Chronic kidney disease and heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources